about
sameAs
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload.Sexual dimorphic regulation of body weight dynamics and adipose tissue lipolysisAngiotensin II, PPAR-gamma and atherosclerosis.Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.PPARgamma-mediated insulin sensitization: the importance of fat versus muscle.Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate.Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.Endothelial dysfunction and its role in diabetic vascular disease.The endothelium and vascular inflammation in diabetes.Proprotein convertase subtilisin/kexin type 3 promotes adipose tissue-driven macrophage chemotaxis and is increased in obesity.Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.High-Fat Diet Induces Unexpected Fatal Uterine Infections in Mice with aP2-Cre-mediated Deletion of Estrogen Receptor Alpha.Metabolic impact of estrogen signalling through ERalpha and ERbeta.Reuptake inhibitors of dopamine, noradrenaline, and serotonin.Sex-specific differences in Type 2 Diabetes Mellitus and dyslipidemia therapy: PPAR agonists.Sex and sex hormone-dependent cardiovascular stress responses.Sex differences in exercise-induced cardiac hypertrophy.Benefit of Blood Pressure Control in Diabetic Patients.Cardiovascular magnetic resonance feature tracking in small animals - a preliminary study on reproducibility and sample size calculation.Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.PCSK9 regulates the chemokine receptor CCR2 on monocytes.Inhibition of Src homology 2 domain-containing phosphatase 1 increases insulin sensitivity in high-fat diet-induced insulin-resistant miceTargeting density-enhanced phosphatase-1 (DEP-1) with antisense oligonucleotides improves the metabolic phenotype in high-fat diet-fed mice.Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesisANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss.Characterization of new PPARgamma agonists: benzimidazole derivatives - the importance of position 2.Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells.Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy.Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.Insulin facilitates monocyte migration: a possible link to tissue inflammation in insulin-resistance.Proprotein convertase furin enhances survival and migration of vascular smooth muscle cells via processing of pro-nerve growth factor.Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.New telmisartan-derived PPARγ agonists: Impact of the 3D-binding mode on the pharmacological profile.Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids.Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.TGF-beta(1) induces peroxisome proliferator-activated receptor gamma1 and gamma2 expression in human THP-1 monocytes.Enhanced insulin signaling in density-enhanced phosphatase-1 (DEP-1) knockout mice.
P50
Q33347137-5E06601A-E9AF-4E63-B11E-044D2DB5FB75Q33550675-93BB1994-9DDC-4B75-AA63-FB68DD1AD75DQ34291294-786B226F-0C9E-42C0-B9AB-F36D2CF3495FQ35650829-8E2BAAB5-D4B8-4809-AA09-7A9BB33D6B8EQ35753591-CF1B27C5-6688-4DBC-8F64-921D998A4018Q36002095-70575173-202A-4F6B-8EC6-F66D83C1C3ADQ36092958-00EC466F-0DD1-4EEB-91D6-E992770B680EQ36524275-380CB689-CCDD-4123-B73A-44713B21FE8AQ36588609-9B61C8C5-1D86-4164-88EA-3633BE313051Q36892486-7422F84A-9276-4B91-9535-076855B6E169Q37075629-BFBEEDBC-FD1C-443E-8D64-E583136BE986Q37236253-556D2C68-DF96-4A4B-A0D5-C2D3D7F85CCCQ37428999-801CB0C0-9A30-4135-9B88-F9266BF4ED0FQ37663213-DE7D5FD4-CB39-481D-9E13-FAFF507A8B74Q37769774-A9E0C408-415D-4300-9B5E-EABC2074C398Q37976366-D5DA6D74-5B6F-4D62-B339-5E68FF937C19Q38048677-1669CB2B-F1F5-4C1F-B927-87637E1DABD0Q38062868-9463518E-0EA0-4936-BD0B-EADFC18E0D7DQ38082439-8704C7C4-A1A7-4CE3-86DF-4F245EA0E496Q38525956-39FEBD2C-CDF2-4CEB-AD0D-3199664E60D9Q38611368-7DD12822-236D-43D2-A4A5-1C7736CDD722Q38623577-67325BAE-76E4-4576-A441-0FED9FC74491Q38715150-07938AA1-6DF0-4043-82F4-65E8B6A22B9CQ39065291-482307C2-6BC0-4130-9FAA-44D41BF76878Q39119938-A9369DB6-F960-44F5-ABFA-B5BB8B3E6CF2Q39282244-B8CA6070-4F14-45FC-B580-F04AF4F5D5DFQ39668755-F279A3E1-B0ED-405F-B59B-7BB4179ADEABQ39770953-2388A87B-2CB9-4769-AE97-B3132FE0D2E7Q39841468-69170951-68C2-4666-A7D4-841E6BFD8534Q39864835-908E8672-C5EE-480D-B3D9-19CB437D5380Q40011487-7704D473-3CD3-4751-B244-0FF2144C0321Q40026843-EE7E67E5-CC4F-4461-B66E-9820A6EFD74EQ40052508-17EDB7E4-B3A8-4BA9-AE84-A3E4CFBD86C2Q40076084-0BECF8CF-3DB8-49A3-AAE9-67BD20B1993BQ40227593-39CAC3EC-87F8-4B44-B35B-78E6C211B1DCQ40400780-D0514727-99C9-4E77-9593-6177502151F2Q40666632-47EDCA72-F748-4037-AA20-4BCB7DBEDF79Q40692915-950CF2AD-379B-4C49-9D2E-32AFAD28B23BQ40700362-FDDC440C-B664-4778-9C95-DBC8C613190FQ41129993-F86314EA-981F-414B-8B71-535AE5742153
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ulrich Kintscher
@ast
Ulrich Kintscher
@en
Ulrich Kintscher
@es
Ulrich Kintscher
@nl
type
label
Ulrich Kintscher
@ast
Ulrich Kintscher
@en
Ulrich Kintscher
@es
Ulrich Kintscher
@nl
prefLabel
Ulrich Kintscher
@ast
Ulrich Kintscher
@en
Ulrich Kintscher
@es
Ulrich Kintscher
@nl
P106
P108
P31
P496
0000-0001-7386-0990